Faughnan ME - Search Results

1

Alternative designs for clinical trials in rare diseases.

Abrahamyan L, Feldman BM, Tomlinson G, Faughnan ME, Johnson SR, Diamond IR, Gupta S. Abrahamyan L, et al. Among authors: faughnan me. Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):313-331. doi: 10.1002/ajmg.c.31533. Epub 2016 Nov 14. Am J Med Genet C Semin Med Genet. 2016. PMID: 27862920 Review.

2

A framework for applying unfamiliar trial designs in studies of rare diseases.

Gupta S, Faughnan ME, Tomlinson GA, Bayoumi AM. Gupta S, et al. Among authors: faughnan me. J Clin Epidemiol. 2011 Oct;64(10):1085-94. doi: 10.1016/j.jclinepi.2010.12.019. Epub 2011 May 6. J Clin Epidemiol. 2011. PMID: 21530171 Review.

3

Rare lung disease research: strategies for improving identification and recruitment of research participants.

Gupta S, Bayoumi AM, Faughnan ME. Gupta S, et al. Among authors: faughnan me. Chest. 2011 Nov;140(5):1123-1129. doi: 10.1378/chest.11-1094. Chest. 2011. PMID: 22045877

4

Embolization for pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia: a decision analysis.

Gupta S, Faughnan ME, Bayoumi AM. Gupta S, et al. Among authors: faughnan me. Chest. 2009 Sep;136(3):849-858. doi: 10.1378/chest.09-0334. Epub 2009 Apr 17. Chest. 2009. PMID: 19376841

5

Alveolar exhaled nitric oxide is elevated in hereditary hemorrhagic telangiectasia.

Gupta S, Zamel N, Faughnan ME. Gupta S, et al. Among authors: faughnan me. Lung. 2009 Jan-Feb;187(1):43-9. doi: 10.1007/s00408-008-9125-3. Epub 2008 Oct 24. Lung. 2009. PMID: 18949516

6

Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation.

Singer LG, Chowdhury NA, Faughnan ME, Granton J, Keshavjee S, Marras TK, Tullis DE, Waddell TK, Tomlinson G. Singer LG, et al. Among authors: faughnan me. Am J Respir Crit Care Med. 2015 Oct 15;192(8):965-73. doi: 10.1164/rccm.201501-0126OC. Am J Respir Crit Care Med. 2015. PMID: 26131729

7

Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial.

Gupta S, Faughnan ME, Lilly L, Hutchison S, Fowler R, Bayoumi AM. Gupta S, et al. Among authors: faughnan me. Clin Gastroenterol Hepatol. 2010 Dec;8(12):1095-8. doi: 10.1016/j.cgh.2010.08.011. Epub 2010 Nov 9. Clin Gastroenterol Hepatol. 2010. PMID: 20816858 Clinical Trial.

8

Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome.

Gupta S, Faughnan ME, Prud'homme GJ, Hwang DM, Munoz DG, Kopplin P. Gupta S, et al. Among authors: faughnan me. Can Respir J. 2008 Apr;15(3):124-6. doi: 10.1155/2008/412836. Can Respir J. 2008. PMID: 18437252 Free PMC article.

9

Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial.

Parikh H, Lui E, Faughnan ME, Al-Hesayen A, Segovia S, Gupta S. Parikh H, et al. Among authors: faughnan me. Trials. 2021 Oct 9;22(1):683. doi: 10.1186/s13063-021-05633-7. Trials. 2021. PMID: 34625098 Free PMC article.

10

Improved survival after liver transplantation in patients with hepatopulmonary syndrome.

Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, Pomier-Layrargues G. Gupta S, et al. Among authors: faughnan me. Am J Transplant. 2010 Feb;10(2):354-63. doi: 10.1111/j.1600-6143.2009.02822.x. Epub 2009 Sep 22. Am J Transplant. 2010. PMID: 19775311 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters